A. Szederjesi

发表

Platelet Count, ADAMTS13 Activity, von Willebrand Factor Level and Survival in Patients with Colorectal Cancer: 5-Year Follow-up Study

Lóránd Barabás, Z. Prohászka, J. Kocsis, 2018, Thrombosis and Haemostasis.

Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen

T. Masszi, R. Horvath, M. Gaddh, 2022, Blood.

Low-Dose Combined Immunosuppression Results In Rapid Remission In Patients With Acquired Hemophilia A

K. Pap, T. Masszi, K. Szabó, 2013 .

Comparison of von Willebrand factor platelet‐binding activity assays: ELISA overreads type 2B with loss of HMW multimers

R. Montgomery, G. Castaman, F. Peyvandi, 2020, Journal of thrombosis and haemostasis : JTH.

An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS‐VWF study

R. Montgomery, G. Castaman, F. Peyvandi, 2018, Journal of thrombosis and haemostasis : JTH.

Identification of the best‐suited donor for generating virus‐specific T cells

J. Sinko, T. Masszi, P. Reményi, 2020, Vox sanguinis.

Early Experience With CliniMACS Prodigy CCS (IFN-gamma) System in Selection of Virus-specific T Cells From Third-party Donors for Pediatric Patients With Severe Viral Infections After Hematopoietic Stem Cell Transplantation

J. Sinko, G. Kriván, M. Réti, 2017, Journal of immunotherapy.

International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain

T. Lindahl, C. Legnani, J. Jespersen, 2018, Journal of Thrombosis and Haemostasis.

Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma

T. Masszi, R. Horvath, Gergely I. B. Varga, 2023, Pathology & Oncology Research.